XML 78 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENT OF CONSOLIDATED CASH FLOWS (USD $)
In Millions, unless otherwise specified
9 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Cash Flows from Operating Activities    
Net income $ 2,382.7 $ 2,135.8
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Provision for doubtful receivables 6.1 17.8
Provision for depreciation and amortization 742.7 677.9
Share-based compensation expense 56.1 50.8
Undistributed earnings of unconsolidated affiliates (7.3) 1.1
Credit for deferred income taxes (205.3) (324.8)
Changes in assets and liabilities:    
Trade, notes and financing receivables related to sales (2,040.9) (978.8)
Inventories (2,032.2) (1,774.6)
Accounts payable and accrued expenses 397.6 571.9
Accrued income taxes payable/receivable 100.4 266.3
Retirement benefits (70.1) 351.1
Other (465.2) (358.4)
Net cash provided by (used for) operating activities (1,135.4) 636.1
Cash Flows from Investing Activities    
Collections of receivables (excluding receivables related to sales) 9,875.4 9,317.4
Proceeds from maturities and sales of marketable securities 125.8 24.5
Proceeds from sales of equipment on operating leases 583.1 522.8
Proceeds from sales of businesses, net of cash sold 30.4 894.4
Cost of receivables acquired (excluding receivables related to sales) (10,832.3) (10,286.7)
Purchases of marketable securities (882.7) (256.1)
Purchases of property and equipment (808.4) (681.5)
Cost of equipment on operating leases acquired (512.3) (397.4)
Acquisitions of businesses, net of cash acquired   (60.8)
Other 5.7 (143.5)
Net cash used for investing activities (2,415.3) (1,066.9)
Cash Flows from Financing Activities    
Increase in total short-term borrowings 1,235.4 844.3
Proceeds from long-term borrowings 8,256.2 3,515.1
Payments of long-term borrowings (4,396.8) (2,795.2)
Proceeds from issuance of common stock 37.1 165.9
Repurchases of common stock (1,225.3) (1,093.2)
Dividends paid (516.3) (422.2)
Excess tax benefits from share-based compensation 16.8 66.8
Other (53.0) (36.3)
Net cash provided by financing activities 3,354.1 245.2
Effect of Exchange Rate Changes on Cash and Cash Equivalents (53.1) 13.3
Net Decrease in Cash and Cash Equivalents (249.7) (172.3)
Cash and Cash Equivalents at Beginning of Period 3,647.2 3,790.6
Cash and Cash Equivalents at End of Period $ 3,397.5 $ 3,618.3